Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)
Code : 9345-355621      Publish Date : Wednesday, April 17, 2019 Visit : 1698

Intl. Congress form | International Congress Report | International Congress Report For Faculty | The report of 21st Asia Pacific League of Associations for Rheumatology Congress in conjunction with...

The report of 21st Asia Pacific League of Associations for Rheumatology Congress in conjunction with the Australian Rheumatology Association (APLAR-ARA 2019) by Dr. Sasan Fallahi
The report of 21st Asia Pacific League of Associations for Rheumatology Congress in conjunction with the Australian Rheumatology Association (APLAR-ARA 2019) by Dr. Sasan Fallahi
Application Code :
762-0119-0044
 
Created Date : Tuesday, February 12, 2019-13:13 13:13:20Update Date : Tuesday, April 16, 2019-11:04 11:04:26
IP Address : 194.225.214.36Submit Date : Tuesday, April 16, 2019-11:08 11:08:18Email : sfallahi@sina.tums.ac.ir
International Congress Form (for Faculty Members)

enlightenedPlease Fill out this form in English and upload all PDF format for the files.enlightened

 
Personal Information
Name: : Sasan
Surname: : Fallahi
School/Research Center: : School of Medicine
Position: : Assistant professor
Tel: : +98-21-55669300
The Abstract that you e-mailed to the Congress Secretary: : http://gsia.tums.ac.ir/images/UserFiles/13150/Forms/762/Abstaract_for_APLAR_2019_.pdf
The Acceptance that is e-mailed from the Congress Secretary: : http://gsia.tums.ac.ir/images/UserFiles/13150/Forms/762/APLAR-ARA_2019__poster_presentation_invitation.pdf
The presentation: : Poster
Title of the Congress: : 21st Asia Pacific League of Associations for Rheumatology Congress in conjunction with the Australian Rheumatology Association (APLAR-ARA 2019)
Title of your Abstract: : The Effect of Face to Face Education on Weight Loss of Overweight Patients with Knee Osteoarthritis
Destination Country: : Australia
From: : Monday, April 8, 2019
To: : Thursday, April 11, 2019
The Congress Reporting

enlightenedPlease Fill out this form in English and upload all PDF format for the files.enlightened

 
Please give a briefing of your own observations and outcomes of the congress : The Rheumatology congress was held in Briisbane, convention and exhibition center at 8-11 April 2019. More than 1000 rheumatologist and trainees attended in the congress from all over the Asia and Australia. The speakers of congress were from the best universities of Asia (such as Japan, Korea, China, Taiwan, India,…), Europe (such as England) and also Australia. Many lectures, oral and poster abstracts and also, industry symposiums sponsored by Pfizer, Amgen, Janssen, Bristol Myers Squibb, Novartis, UCB, etc were presented about updates in all fields of rheumatology. At the end of the congress there were also grand rounds which some interesting rheumatologic cases were presented and the attendants discussed about them. In exhibition center, two new biologic drugs which at present is not accessible in Iran including anti-IL17 (for seronegative spondyloarthropathies), and Baricitinib (JaK inhibitor for rheumatoid arthritis and psoriatic arthritis) were introduced. My poster presentation (about effect of education on weight loss of obese patients with knee osteoarthritis) was also at 11 April in exhibition center. Also, I had a conversation with Professor Brown (chairman of congress from Australia) about diagnostic delay of AS patients and also, with professor Yoon-Kyong-Sung (from Korea) about rebound osteoporosis following cessation of Prolia, and also with preventatives of Lily company about Ixekizumab (anti-IL17) and Baricitinib (Jak inhibitor) and also with Ann Morgan (an ophthalmologist speaker) about treatment of uveitis in seronegative spondyloarthropathies.
The Congress Certification: : http://gsia.tums.ac.ir/images/UserFiles/13150/Forms/762/APLAR-ARA_2019_certificate_of_attendance.pdf
Any Related to Report File :